---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-001940"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2024-01-10T23:59:59+00:00"
generated_at: "2026-06-07T00:53:30.390414+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience, Inc. enters $5M Series A Preferred Stock purchase agreement with NAYA Biosciences

## Summary
- NAYA to purchase up to 1,000,000 shares of Series A Preferred Stock at $5.00/share, total up to $5,000,000.
- First tranche of $500,000 closed on January 4, 2024 for 100,000 shares.
- Remaining tranches: $500,000 each by Jan 19, Feb 2, Feb 16, 2024, plus additional amount for merger.
- Proceeds to support INVO's fertility business, including catch-up on past due payables.
- Agreement is in connection with previously announced merger between INVO and NAYA.

## SEC filing metadata
- accession: 0001493152-24-001940
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2024-01-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315224001940/0001493152-24-001940-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315224001940/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-001940
- JSON: https://secwatch.observer/filing/0001493152-24-001940.json
- Plain text: https://secwatch.observer/filing/0001493152-24-001940.txt

## Key facts
- Material Agreements
  INVO Fertility, Inc. entered into SPA with NAYA Biosciences, Inc. valued at $5.00 per share (effective 2023-12-29).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: NAYA Biosciences, Inc.
  - Value: $5.00 per share
  - Effective: 2023-12-29
  source text: On December 29, 2023, INVO Bioscience, Inc., a Nevada corporation (the “ Company ”) entered into securities purchase agreement (the “ SPA ”) with NAYA Biosciences, Inc., a Delaware corporation (“ NAYA ”) for the purchase of 1,000,000 shares of the Company’s Series A Preferred Stock at a purchase price of $5.00 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315224001940/0001493152-24-001940-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.